The present invention comprises a predicted health risk information acquisition part and a cultured cell production determination part. The predicted health risk information acquisition part acquires information about the predicted health risks of a user. On the basis of the predicted health risk information, the cultured cell production determination part determines whether to produce cultured cells from the cells of the user.
G16H 20/00 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
C12Q 1/02 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
This somatic cell production system is provided with: a pre-introduction cell liquid supply channel 20 through which a solution containing pre-introduction cells is passed; a factor introduction device 30 which is connected to the pre-introduction cell liquid supply channel 20 and which introduces a somatic cell inducing factor into the pre-introduction cells so as to prepare inducing factor-introduced cells; and a cell preparation device 40 for culturing the inducing factor-introduced cells to prepare somatic cells.
The present disclosure provides a production method for artificial pluripotent stem cells, the method comprising preparing somatic cells, and introducing a Sendai virus including reprogramming factor RNA into the somatic cell. The present disclosure also provides a production method for artificial pluripotent stem cells, the method comprising preparing somatic cells, introducing reprogramming factor RNA into the somatic cells using an RNA transfection reagent, and reprogramming the somatic cells in a gel culture medium.
This insurance management system is provided with an insurance management server, wherein the insurance management server has a reception unit that receives a prescribed amount of money deposited by a user for a prescribed period, a production request transmission unit that transmits a customer's specific cell production request to a cell management server for managing production of specific cells, when the accumulated amount of money deposited by the user and received by the reception unit satisfies a first condition; and a use request transmission unit that transmits a customer's specific cell use request to the cell management server when the accumulated amount of money received by the reception unit satisfies a second condition larger in amount or longer in period than the first condition.
This cell treatment device is provided with: a factor introduction device 30 for introducing a pluripotent induction factor into cells so as to prepare induction factor-introduced cells; and a reprogramming suspension culture vessel for culturing the induction factor-introduced cells that have been prepared by the factor introduction device 30.
The present invention provides a nerve cell production method that involves preparing stem cells and then introducing inducing-factor RNA into the stem cells and allowing differentiation into nerve cells. The present invention also provides a nerve cell production method that involves preparing cells, introducing reprogramming-factor RNA into the cells, introducing inducing-factor RNA into the cells into which the reprogramming-factor RNA was introduced, and allowing differentiation into nerve cells.
C12N 15/88 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using liposome vesicle
7.
CELL PROCESSING SYSTEM AND CELL PROCESSING APPARATUS
This cell processing system is provided with a housing 601, an outer housing 701 which contains the housing 601, an intake air purification filter 602 which is provided in the housing 601, and purifies a gas suctioned from the exterior of the housing 601, a circulation device which circulates a gas in and out of the housing 601, in the outer housing 701, so that the gas in the outer housing 701 is suctioned into the housing 601 through the intake air purification filter 602, and the gas in the housing 601 is discharged into the outer housing 701, and a cell processing device which is disposed in the housing 601, and which is for processing cells.
A stem cell production system provided with a preintroduction cell-feeding solution channel 20 through which a solution containing cells passes, an induction factor-feeding solution mechanism 21 for feeding a pluripotency induction factor to the preintroduction cell-feeding solution channel 20, a factor introduction device 30 connected to the preintroduction cell-feeding solution channel 20 for making cells with induction factor introduced by introducing the pluripotency induction factor into the cells, a cell mass-making device 40 for making multiple cell masses comprising stem cells by culturing the cells with induction factor introduced, and a packaging device 100 for sequentially packaging each of the multiple cell masses.
The present invention provides a stem cell manufacturing system comprising: a sending channel (20) through which a solution containing cells flows; an apparatus (30) which is connected to the sending channel (20) and transfers a pluripotency inducer into the cells to produce cells harboring the inducer; and an apparatus (40) which cultures the cells harboring the inducer to produce cell clusters consisting of stem cells.